bpc-157 pharmacokinetics subcutaneous as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers bpc-157 pharmacokinetics half-life study Bpc
Description
Neuroprotection Against Parkinsons Models MPTP selectively destroys nigrostriatal dopaminergic neurons, producing tremor, rigidity, akinesia, and catalepsy in rodents
Support a balanced, resilient immune response by managing pro-inflammatory signaling
Reported events include injection site reactions, mild dizziness, nasopharyngitis, and transient fatigue
Hasan GM, Anwar S, Shamsi A et al (2024) The neuroprotective potential of phytochemicals in traumatic brain injury: mechanistic insights and pharmacological implications
